Weekly View

ICER Weekly View 10-13-17

From the desk of Mitchell Stein   Good morning. It’s Friday the 13th, so my sympathy to those of you with triskaidekaphobia. Actually, given the ACA chaos we are all waking up to, my sympathy to all of us. But we’re not here to talk about that, on the pharma front this week we’ll look […]

Read More

ICER Weekly View 10-06-17

From the desk of Mitchell Stein   Good morning. With no repeal bill taking up bandwidth, lots of drug pricing news this week. (Although with expected CMS action on the birth control mandate today and an executive order on association plans next week, I don’t expect the ACA lull to last.) This week we’ll look at: […]

Read More

ICER Weekly View 09-29-17

From the desk of Mitchell Stein   Good morning. As someone who was at my computer at 5 AM working on today’s edition, let me pause to acknowledge National Coffee Day – coffee helps make all this magic possible. Before we get started, I also want to call your attention to one of today’s stories […]

Read More

ICER Weekly View 09-22-17

From the desk of Mitchell Stein   Good morning. Today at 4:02 PM Eastern is the Autumnal Equinox, the official end of summer. What, you thought I was going to say something snarky about Graham-Cassidy? No, I would never do that… This week we’ll look at: ICER in the news – ICER’s Dupixent results, ICER’s […]

Read More

ICER Weekly View 09-15-17

From the desk of Mitchell Stein   Good morning. Drug patent maneuvering, more health care reform plans, hurricanes – there are days it can be hard to keep perspective – so let’s start today with a look at the grandeur of Saturn as captured by the Cassini space probe, which by the time you read […]

Read More

ICER Weekly View 09-08-17

From the desk of Mitchell Stein   Good morning. Before we start, a wish of safety to everyone suffering from nature’s recent fury and those about to experience it. Before we get to this week’s news, allow me to note that over the past several years, ICER has worked diligently to improve the incorporation of […]

Read More

ICER Weekly View 9-1-17

Good morning. Weekly View will be taking a brief hiatus this week but will be back next week with all of your industry news. If you’re looking for some light reading to tide you over during the long weekend, here are a few articles we recommend. On Wednesday, the FDA approved a long-anticipated CAR-T therapy […]

Read More

ICER Weekly View 08-25-17

From the desk of Mitchell Stein   Good morning. Last week we were reminded of nature’s beauty with the eclipse – this week we’re observers of nature’s power as Harvey (the hurricane, not the rabbit) heads towards Texas. Us nerds like data in all forms, so here are some numbers for you to start your […]

Read More

ICER Weekly View 08-18-17

From the desk of Mitchell Stein   Good morning. Before we get started, let’s take a minute to talk about the solar eclipse happening on Monday. During a week where the ugliness of humanity has been on display, I find it helps to pause and appreciate the wonder and majesty of the universe. It’s only […]

Read More

ICER Weekly View 08-11-17

From the desk of Mitchell Stein   Good morning. Another beautiful day here in Maine. I hope it’s equally nice where you are and everyone is enjoying their summer. Before we get to today’s news, a reminder that I welcome your feedback – both positive and negative. Now, on to the news: ICER in the news […]

Read More

Sign-up to have the Weekly View delivered to your inbox every Friday morning.

SIGN UP